Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus (Q44241882)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 May 2008

Language	Label	Description	Also known as
English	Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus	scientific article published on 16 May 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

vesicular stomatitis

1 reference

based on heuristic

inferred from title

8

object named as

Klaus Uberla

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Matthias Tenbusch

2

object named as

Matthias Tenbusch

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Vladimir V Temchura

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Godwin Nchinda

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ghulam Nabi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Bettina Tippler

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Maryna Zelenyuk

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Oliver Wildner

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Seraphin Kuate

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

16 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

29-30

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3662-3672

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Dendritic cells or their exosomes are effective biotherapies of cancer.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Tumor-derived exosomes: a new source of tumor rejection antigens

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Dendritic cell-derived exosomes as cell-free peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Prospects for exosomes in immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Pathway of vesicular stomatitis virus entry leading to infection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Multiple antigen-specific processing pathways for activating naive CD8 T cells in vivo

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Regulation of phagosome maturation by signals from toll-like receptors

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.069

7 January 2021

Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/18538453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A fusion-defective mutant of the vesicular stomatitis virus glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/18538453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2008.04.069

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

release_hqk3rm3fxvfkpf2t7anbk7bhf4

1 reference

https://api.fatcat.wiki/v0/release/hqk3rm3fxvfkpf2t7anbk7bhf4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

https://api.fatcat.wiki/v0/release/hqk3rm3fxvfkpf2t7anbk7bhf4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44241882&oldid=2108863464"